Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ)

NCT03921528 is registered in ClinicalTrials.gov with Scholar Rock, Inc. as lead sponsor.

NCT NCT03921528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03921528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ)
Lead sponsor
Scholar Rock, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 22, 2019
Completion date
February 28, 2024
Enrollment
58 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

atrophy, muscular atrophy, muscular atrophy, spinal, neuromuscular diseases, neuromuscular manifestations, sma, spinal muscular atrophy, spinal muscular atrophy type 2, spinal muscular atrophy type 3